Search - tctmd.com

Displaying 61 - 80 of 95

Sort: Relevancy | Date

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Daily News

Artificially Created Thrombus May Aid in Cases of Endovascular Perforation

L.A. McKeown

July 25, 2017

News Daily News

Readmission for Critical Limb Ischemia Common and Largely Unplanned

L.A. McKeown

April 10, 2017

News Conference News ISET 2017

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

Caitlin E. Cox

February 15, 2017

News Conference News TCT 2016

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

L.A. McKeown

November 07, 2016

News Conference News VIVA 2016

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

L.A. McKeown

October 12, 2016

News Conference News VIVA 2016

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

L.A. McKeown

September 21, 2016

News Conference News VIVA 2016

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

L.A. McKeown

September 20, 2016

News Industry News

REALITY Trial Enrolls First Patient in Study Evaluating Medtronic Directional Atherectomy and Drug-Coated Balloon in PAD Treatment

July 28, 2016

News Industry News

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

February 08, 2016

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Daily News

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

L.A. McKeown

October 26, 2015

News Daily News

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

L.A. McKeown

October 05, 2015

News Industry News

Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters

August 03, 2015

News Industry News

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

July 29, 2015

News Daily News

ISET Abstracts Shed Light on Novel Therapies for PAD

Caitlin E. Cox

February 04, 2015

News Daily News

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Salynn Boyles

December 15, 2014

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Caitlin E. Cox

October 24, 2014

News Daily News

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

Todd Neale

October 10, 2014

News Daily News

PTA-First Strategy Matches Primary Stenting for Popliteal Artery Disease

Caitlin E. Cox

June 28, 2013

Advertisement

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

Artificially Created Thrombus May Aid in Cases of Endovascular Perforation

Readmission for Critical Limb Ischemia Common and Largely Unplanned

Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

REALITY Trial Enrolls First Patient in Study Evaluating Medtronic Directional Atherectomy and Drug-Coated Balloon in PAD Treatment

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

ISET Abstracts Shed Light on Novel Therapies for PAD

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

PTA-First Strategy Matches Primary Stenting for Popliteal Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content